IL17A and cancer: This abnormal myelopoiesis in cancer and chronic inflammation is induced by several cytokines, including interleukin (IL)-17A, G-CSF, GM-CSF, and TNF (tumor necrosis factor)-α, as well as transcription factor ROR1C [28].